Stable, topically applicable cosmetic/dermatological sunscreen compositions, well suited for the UV-photoprotection of human skin/keratinous materials, contain a thus effective amount of at least one novel amine, amide, sulphonamide or carbamate substituted benzalmalonic salt compound.

The invention relates to compounds that selectively bind to phospholipid membranes having the features of membranes of apoptotic cells, pharmaceutical compositions comprising the same and therapeutic and diagnostic methods using thereof.

The present invention relates to novel ketone compounds, compositions comprising ketone compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising a ketone compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders...

This invention relates to the use of the succinic acid molecule to stimulate the Citric Acid Cycle in humans and animals and thus relieve those metabolic disorders caused by a deficiency in the Citric Acid Cycle in humans and animals.

The present invention relates to a pharmaceutical composition and a method for treating a compulsive disorder using a NAALADase inhibitor.

The invention relates to an agent for the prophylaxis and/or therapy of conditions associated with a disorder of bone formation. It contains alkali metal citrates and/or alkali metal lactates and/or alkali metal malates, optionally together with one or more active substances selected from vitamin K, calcium salts and vitamin D. The agent preferably contains potassium citrates and/or sodium citrates or potassium lactates and/or sodium lactates and serves for the prophylaxis and/or therapy of oste...

The invention provides a method for the treatment of a condition, disorder or a disease of the skin by administering a pharmaceutically acceptable oxalate. Preferably, the oxalate is a transition metal oxalate and the pharmaceutically acceptable carrier is an ointment.

A method whereby the glucose metabolism in an individual showing evidence of dysregulation, as is found in insulin resistance, reactive hyperglycemia and/or elevated blood sugar levels and/or diabetes, is improved when that person receives an appropriate oral administration of (-)-hydroxycitric acid. The potassium salt of (-)-hydroxycitric acid is the preferred form of the compound, followed by the sodium salt. The regulation of glucose levels over any given period of time may be improved with a...

An oxalic acid or oxalate composition and method of treatment of warm blooded animals including humans and pets is provided which includes at least one therapeutically effective form of oxalic acid or oxalate selected, for example, from oxalic acid in a free acid, ester, lactone or salt form, oxalates including sodium oxalate, a nutritional supplement containing oxalic acid or oxalate, oxalic acid dihydrate, anhydrous oxalic acid, oxamide, oxalate salts, natural or processed foods including mold...

A single medicine oxalic acid or oxalate composition or "magic bullet" and method of treatment or prevention of warm-blooded animals including humans and pets for infectious or pathogenic microbial, bacterial, or viral disease, chemopreventiong of bacterial or viral infections, and the like, is provided which includes at least one therapeutically effective form of oxalic acid or oxalate selected from oxalic acid in a free acid, ester, lactone or salt form and oxalate including sodium oxalate, ox...